Showing results (161-170 of 177) with videos related to
Sort By:
Pageof 18
Hepatology (Baltimore, Md.)|June 16, 2021
TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion InjuryJunjie Zhou, Manli Hu, Meiling He, et al.The Journal of Clinical Investigation|January 11, 2024
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthaseSuowen Xu, Xiumei Wu, Sichen Wang, et al.Nature Medicine|February 21, 2017
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primatesPi-Xiao Wang, Yan-Xiao Ji, Xiao-Jing Zhang, et al.Nature Medicine|October 7, 2017
Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primatesPi-Xiao Wang, Yan-Xiao Ji, Xiao-Jing Zhang, et al.Nature Medicine|December 12, 2017
An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injuryXiao-Jing Zhang, Xu Cheng, Zhen-Zhen Yan, et al.Nature Medicine|January 2, 2018
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitisYan-Xiao Ji, Zan Huang, Xia Yang, et al.Gut|May 11, 2026
Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinomaQing Li, Suiqing Zhou, Liren Zhang, et al.Gut|May 21, 2026
Blocking MOXD1-derived ACOX1 peroxisome trafficking suppresses metabolic dysfunction-associated steatohepatitisMei Li, Jinquan Zhang, Yunfan Yang, et al.Science Translational Medicine|February 14, 2024
Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progressionLan Bai, Weiyi Qu, Xu Cheng, et al.Gut|April 28, 2026
JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1Qing Li, Kai Yu, Suiqing Zhou, et al.Pageof 18